VistaGen Therapeutics, Inc. Appoints Industry Veteran Shawn Singh as Chief Executive Officer
8/20/2009 10:51:30 AM
More...
|
VistaGen Therapeutics, Inc. and Capsant Neurotechnologies Ltd. Sign Strategic Stem Cell Technology Commercialization Agreement
1/15/2009 10:15:23 AM
More...
|
VistaGen Therapeutics, Inc. And Wisconsin Alumni Research Foundation (WARF) Sign License Agreement for Human Embryonic Stem Cell Technology
12/18/2008 11:25:26 AM
More...
|
VistaGen Therapeutics, Inc. Receives Significant Stem Cell Tools and Technologies Grant from California Institute for Regenerative Medicine
12/16/2008 2:00:03 PM
More...
|
VistaGen Therapeutics, Inc. and Leading Stem Cell Researchers Pinpoint Key Biochemical Pathways Involved in Generating Large Numbers of Heart Cells from Embryonic Stem Cells
10/15/2008 1:57:47 PM
More...
|
Newly-Issued Broad Composition of Matter Patent Protects VistaGen Therapeutics, Inc.’s ES-Cell Derived Pluripotent Precursor Cells
6/16/2008 1:08:16 PM
More...
|
VistaGen Therapeutics, Inc. Licenses Customized Stem Cell-Based Drug Discovery Assays to Sanwa Kagaku Kenkyusho, a Japanese Pharmaceutical Company
5/22/2008 10:08:17 AM
More...
|
VistaGen Therapeutics, Inc. Collaborates with Canadian, U.S., and British Researchers To Isolate Earliest Embryonic Stem Cell-Derived Human Cardiac Cell
4/23/2008 11:18:55 AM
More...
|
VistaGen Therapeutics, Inc. Announces Broad Stem Cell R&D Alliance With Toronto's University Health Network and The McEwen Centre For Regenerative Medicine
3/12/2008 9:18:57 AM
More...
|
VistaGen Therapeutics, Inc. Names Agustin de la Calle, Ph.D. as Vice President, Business Development
12/4/2007 10:48:36 AM
More...
|
|